StockData
Altamira Therapeutics Ltd. logo

Altamira Therapeutics Ltd. (CYTOF) stock

CYTOFOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2024, năm kết thúc ngày Dec 31, 2024Last filing: 20-F on Apr 30, 2025
$0.09+0.00 (0.00%)

Close on Oct 19, 2026

Earnings

Altamira Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Altamira Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Altamira Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Altamira Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Altamira Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?